Structural biology of complement receptors
暂无分享,去创建一个
M. Vega | Jorge Santos-Lo ´ pez | Karla de la Paz | Francisco J. Ferna ´ ndez | Hyun Ho Park | Laure Yatime | Brandon L. Garcia
[1] V. Holers. Complement therapeutics are coming of age in rheumatology , 2023, Nature Reviews Rheumatology.
[2] Xi Cheng,et al. Revealing the signaling of complement receptors C3aR and C5aR1 by anaphylatoxins , 2023, Nature chemical biology.
[3] C. Kemper,et al. Complosome — the intracellular complement system , 2023, Nature Reviews Nephrology.
[4] D. Fairlie,et al. Ras-Related Protein Rab5a Regulates Complement C5a Receptor Trafficking, Chemotaxis, and Chemokine Secretion in Human Macrophages , 2023, Journal of Innate Immunity.
[5] Xiaowen Tian,et al. Mechanism of activation and biased signaling in complement receptor C5aR1 , 2023, Cell Research.
[6] John D Lambris,et al. Complement‐targeted therapeutics: An emerging field enabled by academic drug discovery , 2023, American journal of hematology.
[7] J. Paz,et al. Complement: The Road Less Traveled. , 2023, Journal of immunology.
[8] L. Roumenina,et al. C3‐dependent effector functions of complement , 2022, Immunological reviews.
[9] K. Ley,et al. Structural Basis of β2 Integrin Inside—Out Activation , 2022, Cells.
[10] A. Ruocco,et al. The role of C5a-C5aR1 axis in bone pathophysiology: A mini-review , 2022, Frontiers in Cell and Developmental Biology.
[11] J. McLellan,et al. Structural basis for non-canonical integrin engagement by Bordetella adenylate cyclase toxin , 2022, Cell reports.
[12] J. Köhl,et al. Anaphylatoxins spark the flame in early autoimmunity , 2022, Frontiers in Immunology.
[13] N. S. Laursen,et al. Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2 , 2022, The Journal of biological chemistry.
[14] S. Rodríguez de Córdoba,et al. The crystal structure of iC3b-CR3 αI reveals a modular recognition of the main opsonin iC3b by the CR3 integrin receptor , 2022, Nature Communications.
[15] C. Hoffmann,et al. GPCR kinase knockout cells reveal the impact of individual GRKs on arrestin binding and GPCR regulation , 2022, Nature communications.
[16] T. Woodruff,et al. Development of Potent and Selective Agonists for Complement C5a Receptor 1 with In Vivo Activity. , 2021, Journal of medicinal chemistry.
[17] Stephen P. H. Alexander,et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors , 2021, British journal of pharmacology.
[18] S. Endow. Faculty Opinions recommendation of Highly accurate protein structure prediction with AlphaFold. , 2021, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[19] Oriol Vinyals,et al. Highly accurate protein structure prediction with AlphaFold , 2021, Nature.
[20] A. Erdei,et al. New aspects in the regulation of human B cell functions by complement receptors CR1, CR2, CR3 and CR4. , 2021, Immunology letters.
[21] D. Ricklin,et al. The Promiscuous Profile of Complement Receptor 3 in Ligand Binding, Immune Modulation, and Pathophysiology , 2021, Frontiers in Immunology.
[22] G. Varrassi,et al. Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives , 2021, Biomedicines.
[23] D. Hilger. The role of structural dynamics in GPCR‐mediated signaling , 2021, The FEBS journal.
[24] P. Proost,et al. Complement Receptors and Their Role in Leukocyte Recruitment and Phagocytosis , 2021, Frontiers in Cell and Developmental Biology.
[25] Z. Bajtay. Biologia Futura: stories about the functions of β2-integrins in human phagocytes , 2021, Biologia Futura.
[26] T. Woodruff,et al. Intrinsic bias at non-canonical, β-arrestin-coupled seven transmembrane receptors , 2021, bioRxiv.
[27] D. Alsteens,et al. Submolecular probing of the complement C5a receptor–ligand binding reveals a cooperative two-site binding mechanism , 2020, Communications biology.
[28] Xu Han,et al. Complement factor C4a does not activate protease‐activated receptor 1 (PAR1) or PAR4 on human platelets , 2020, Research and practice in thrombosis and haemostasis.
[29] Ming-hui Zhao,et al. The Complement C3a and C3a Receptor Pathway in Kidney Diseases , 2020, Frontiers in Immunology.
[30] T. Woodruff,et al. C5aR2 Activation Broadly Modulates the Signaling and Function of Primary Human Macrophages , 2020, The Journal of Immunology.
[31] Xu Han,et al. Complement factor C4a does not activate protease activated receptor 1 (PAR1) or PAR4 on human platelets , 2020, bioRxiv.
[32] T. Woodruff,et al. Emerging Insights into the Structure and Function of Complement C5a Receptors. , 2020, Trends in biochemical sciences.
[33] T. Springer,et al. Complement Receptor 3 Forms a Compact High-Affinity Complex with iC3b , 2020, The Journal of Immunology.
[34] J. García-Nafría,et al. Cryo-Electron Microscopy: Moving Beyond X-Ray Crystal Structures for Drug Receptors and Drug Development. , 2020, Annual review of pharmacology and toxicology.
[35] E. Shakhnovich,et al. Common activation mechanism of class A GPCRs , 2019, eLife.
[36] M. Petzl-Erler,et al. Complement Receptor 1 (CR1, CD35) Polymorphisms and Soluble CR1: A Proposed Anti-inflammatory Role to Quench the Fire of “Fogo Selvagem” Pemphigus Foliaceus , 2019, Front. Immunol..
[37] Z. Mackey,et al. CRIg plays an essential role in intravascular clearance of bloodborne parasites by interacting with complement , 2019, Proceedings of the National Academy of Sciences.
[38] B. Morgan,et al. Compendium of current complement therapeutics. , 2019, Molecular immunology.
[39] B. Geisbrecht,et al. The C1q Receptors: Focus on gC1qR/p33 (C1qBP, p32, HABP-1)1. , 2019, Seminars in immunology.
[40] L. Hviid,et al. Cerebral Plasmodium falciparum malaria: The role of PfEMP1 in its pathogenesis and immunity, and PfEMP1‐based vaccines to prevent it , 2019, Immunological reviews.
[41] M. T. B. Geller,et al. Molecular , 2019, Modern Pathology.
[42] You-Wen He,et al. The Complement Receptors C3aR and C5aR Are a New Class of Immune Checkpoint Receptor in Cancer Immunotherapy , 2019, Front. Immunol..
[43] A. Rosanas-Urgell,et al. Complement Receptor 1 availability on red blood cell surface modulates Plasmodium vivax invasion of human reticulocytes , 2019, Scientific Reports.
[44] S. Rodríguez de Córdoba,et al. The Antimicrobials Anacardic Acid and Curcumin Are Not-Competitive Inhibitors of Gram-Positive Bacterial Pathogenic Glyceraldehyde-3-Phosphate Dehydrogenase by a Mechanism Unrelated to Human C5a Anaphylatoxin Binding , 2019, Front. Microbiol..
[45] T. Woodruff,et al. Partial ligand-receptor engagement yields functional bias at the human complement receptor, C5aR1 , 2019, The Journal of Biological Chemistry.
[46] J. R. Regueiro,et al. Lymphocyte integration of complement cues. , 2019, Seminars in cell & developmental biology.
[47] T. Vorup-Jensen,et al. Structural Immunology of Complement Receptors 3 and 4 , 2018, Front. Immunol..
[48] Guohui Li,et al. Intramembrane ionic protein–lipid interaction regulates integrin structure and function , 2018, PLoS biology.
[49] M. Pirooznia,et al. Complement receptor CD46 co-stimulates optimal human CD8+ T cell effector function via fatty acid metabolism , 2018, Nature Communications.
[50] W. Weis,et al. The Molecular Basis of G Protein-Coupled Receptor Activation. , 2018, Annual review of biochemistry.
[51] M. van Lookeren Campagne,et al. Pathogen clearance and immune adherence "revisited": Immuno-regulatory roles for CRIg. , 2018, Seminars in immunology.
[52] K. Chung,et al. Orthosteric and allosteric action of the C5a receptor antagonists , 2018, Nature Structural & Molecular Biology.
[53] R. Wallis,et al. Structure of the C1r–C1s interaction of the C1 complex of complement activation , 2018, Proceedings of the National Academy of Sciences.
[54] G. Bottegoni,et al. Structure of the complement C5a receptor bound to the extra-helical antagonist NDT9513727 , 2018, Nature.
[55] S. Gómez,et al. Pathogens' toolbox to manipulate human complement. , 2017, Seminars in cell & developmental biology.
[56] A. Erdei,et al. Non-identical twins: Different faces of CR3 and CR4 in myeloid and lymphoid cells of mice and men. , 2017, Seminars in cell & developmental biology.
[57] J. Köhl,et al. Novel insights into the expression pattern of anaphylatoxin receptors in mice and men. , 2017, Molecular immunology.
[58] Owen A. Hawksworth,et al. New concepts on the therapeutic control of complement anaphylatoxin receptors. , 2017, Molecular immunology.
[59] M. Garstka,et al. The Controversial C5a Receptor C5aR2: Its Role in Health and Disease , 2017, Journal of immunology research.
[60] G. Georgiou,et al. IgG Fc domains that bind C1q but not effector Fcγ receptors delineate the importance of complement-mediated effector functions , 2017, Nature Immunology.
[61] S. Muyldermans,et al. Structural evaluation of a nanobody targeting complement receptor Vsig4 and its cross reactivity. , 2017, Immunobiology.
[62] S. Rodríguez de Córdoba,et al. Crystal Structure of Glyceraldehyde-3-Phosphate Dehydrogenase from the Gram-Positive Bacterial Pathogen A. vaginae, an Immunoevasive Factor that Interacts with the Human C5a Anaphylatoxin , 2017, Front. Microbiol..
[63] T. Springer,et al. Distinct recognition of complement iC3b by integrins αXβ2 and αMβ2 , 2017, Proceedings of the National Academy of Sciences of the United States of America.
[64] Michael Loran Dustin. Complement Receptors in Myeloid Cell Adhesion and Phagocytosis , 2016, Microbiology spectrum.
[65] J. Atkinson,et al. Evolution of the complement system: from defense of the single cell to guardian of the intravascular space , 2016, Immunological reviews.
[66] C. Floudas,et al. Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling , 2016, Immunology and cell biology.
[67] B. Schiøtt,et al. Structural Basis for Simvastatin Competitive Antagonism of Complement Receptor 3* , 2016, The Journal of Biological Chemistry.
[68] A. Sher,et al. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4+ T cells , 2016, Science.
[69] John D Lambris,et al. New milestones ahead in complement-targeted therapy. , 2016, Seminars in immunology.
[70] Todd H. Oakley,et al. The last common ancestor of most bilaterian animals possessed at least 9 opsins , 2016, bioRxiv.
[71] G. Bajic,et al. The cationic peptide LL-37 binds Mac-1 (CD11b/CD18) with a low dissociation rate and promotes phagocytosis. , 2016, Biochimica et biophysica acta.
[72] John D Lambris,et al. Regulators of complement activity mediate inhibitory mechanisms through a common C3b‐binding mode , 2016, The EMBO journal.
[73] T. Springer,et al. Leukocyte integrin αLβ2 headpiece structures: The αI domain, the pocket for the internal ligand, and concerted movements of its loops , 2016, Proceedings of the National Academy of Sciences.
[74] S. Barnum. C4a: An Anaphylatoxin in Name Only , 2015, Journal of Innate Immunity.
[75] A. Razim,et al. Pathogens , 2014, Virulence.
[76] P. Monk,et al. C5a2 can modulate ERK1/2 signaling in macrophages via heteromer formation with C5a1 and β‐arrestin recruitment , 2014, Immunology and cell biology.
[77] V. Holers. Complement and its receptors: new insights into human disease. , 2014, Annual review of immunology.
[78] J. Köhl,et al. Novel roles for complement receptors in T cell regulation and beyond. , 2013, Molecular immunology.
[79] T. Springer,et al. An internal ligand-bound, metastable state of a leukocyte integrin, αXβ2 , 2013, The Journal of cell biology.
[80] A. Cowman,et al. Using Mutagenesis and Structural Biology to Map the Binding Site for the Plasmodium falciparum Merozoite Protein PfRh4 on the Human Immune Adherence Receptor* , 2013, The Journal of Biological Chemistry.
[81] D. Fairlie,et al. C5a, but not C5a‐des Arg, induces upregulation of heteromer formation between complement C5a receptors C5aR and C5L2 , 2013, Immunology and cell biology.
[82] Thomas Vorup-Jensen,et al. Structural insight on the recognition of surface-bound opsonins by the integrin I domain of complement receptor 3 , 2013, Proceedings of the National Academy of Sciences.
[83] F. J. Fernández,et al. Technologies to keep an eye on: alternative hosts for protein production in structural biology. , 2013, Current opinion in structural biology.
[84] Bryan L. Roth,et al. Structure of the human smoothened receptor bound to an antitumour agent , 2013, Nature.
[85] M. Babu,et al. Molecular signatures of G-protein-coupled receptors , 2013, Nature.
[86] G. Larson,et al. LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins. , 2013, Journal of proteome research.
[87] H. Subramanian,et al. Phosphorylation of C3a Receptor at Multiple Sites Mediates Desensitization, β-Arrestin-2 Recruitment and Inhibition of NF-κB Activity in Mast Cells , 2012, PloS one.
[88] Danny W. Wilson,et al. The Plasmodium falciparum Erythrocyte Invasion Ligand Pfrh4 as a Target of Functional and Protective Human Antibodies against Malaria , 2012, PloS one.
[89] Michael Loran Dustin,et al. Integrin inside-out signaling and the immunological synapse. , 2012, Current opinion in cell biology.
[90] J. Xiong,et al. Stable Coordination of the Inhibitory Ca2+ Ion at the Metal Ion-Dependent Adhesion Site in Integrin CD11b/CD18 by an Antibody-Derived Ligand Aspartate: Implications for Integrin Regulation and Structure-Based Drug Design , 2011, The Journal of Immunology.
[91] H. Subramanian,et al. Regulation of C3a Receptor Signaling in Human Mast Cells by G Protein Coupled Receptor Kinases , 2011, PloS one.
[92] H. Subramanian,et al. Distinct and Shared Roles of β-Arrestin-1 and β-Arrestin-2 on the Regulation of C3a Receptor Signaling in Human Mast Cells , 2011, PloS one.
[93] D. Isenman,et al. A Crystal Structure of the Complex Between Human Complement Receptor 2 and Its Ligand C3d , 2011, Science.
[94] Yutaka Ito,et al. Cellular structural biology. , 2010, Current opinion in structural biology.
[95] Dave Richard,et al. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand , 2010, Proceedings of the National Academy of Sciences.
[96] Can Xie,et al. Structure of an integrin with an αI domain, complement receptor type 4 , 2010, The EMBO journal.
[97] G. Zaman,et al. C5a-Stimulated Recruitment of β-Arrestin2 to the Nonsignaling 7-Transmembrane Decoy Receptor C5L2 , 2009, Journal of biomolecular screening.
[98] J. Köhl,et al. The role of the anaphylatoxins in health and disease. , 2009, Molecular immunology.
[99] J. Prechl,et al. Expression and role of CR1 and CR2 on B and T lymphocytes under physiological and autoimmune conditions. , 2009, Molecular immunology.
[100] John D Lambris,et al. Structure of C3b-factor H and implications for host protection by complement regulators , 2009, Nature Immunology.
[101] P. Monk,et al. The human complement fragment receptor, C5L2, is a recycling decoy receptor , 2009, Molecular immunology.
[102] M. Del Poeta,et al. App1: An Antiphagocytic Protein That Binds to Complement Receptors 3 and 21 , 2009, The Journal of Immunology.
[103] V. M. Holers,et al. Solution structure of the complex formed between human complement C3d and full-length complement receptor type 2. , 2008, Journal of molecular biology.
[104] R. Khera,et al. Complement Receptor 1: Disease associations and therapeutic implications , 2008, Molecular Immunology.
[105] F. Boulay,et al. Complement Component 5a Receptor Oligomerization and Homologous Receptor Down-regulation* , 2008, Journal of Biological Chemistry.
[106] M. Oppermann,et al. Role of the carboxyl terminal di-leucine in phosphorylation and internalization of C5a receptor. , 2008, Biochimica et biophysica acta.
[107] S. Hoffmann,et al. Structural Insight into the Function of Myelin Basic Protein as a Ligand for Integrin αMβ21 , 2008, The Journal of Immunology.
[108] John D. Lambris,et al. Complement evasion by human pathogens , 2008, Nature Reviews Microbiology.
[109] S. Perkins,et al. The partly folded back solution structure arrangement of the 30 SCR domains in human complement receptor type 1 (CR1) permits access to its C3b and C4b ligands. , 2008, Journal of molecular biology.
[110] John D Lambris,et al. Complement-targeted therapeutics , 2007, Nature Biotechnology.
[111] E. Mitchell,et al. A Structural Hypothesis for the Transition between Bent and Extended Conformations of the Leukocyte β2 Integrins* , 2007, Journal of Biological Chemistry.
[112] P. Monk,et al. Function, structure and therapeutic potential of complement C5a receptors , 2007, British journal of pharmacology.
[113] R. Roozendaal,et al. Complement receptors CD21 and CD35 in humoral immunity , 2007, Immunological reviews.
[114] M. van Lookeren Campagne,et al. Macrophage complement receptors and pathogen clearance , 2007, Cellular microbiology.
[115] M. Cybulsky,et al. Getting to the site of inflammation: the leukocyte adhesion cascade updated , 2007, Nature Reviews Immunology.
[116] G. Remuzzi,et al. The interactive Factor H–atypical hemolytic uremic syndrome mutation database and website: update and integration of membrane cofactor protein and Factor I mutations with structural models , 2007, Human mutation.
[117] M. Oppermann,et al. Dynamics of Protein Kinase C-mediated Phosphorylation of the Complement C5a Receptor on Serine 334* , 2007, Journal of Biological Chemistry.
[118] G. Nikiforovich,et al. A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor , 2007, Journal of Biological Chemistry.
[119] G. Nikiforovich,et al. A Comprehensive Structure-Function Map of the Intracellular Surface of the Human C5a Receptor , 2007, Journal of Biological Chemistry.
[120] Ian S Hagemann,et al. Random Mutagenesis of the Complement Factor 5a (C5a) Receptor N Terminus Provides a Structural Constraint for C5a Docking* , 2006, Journal of Biological Chemistry.
[121] A. Higginbottom,et al. The Role of the N-terminal Domain of the Complement Fragment Receptor C5L2 in Ligand Binding* , 2006, Journal of Biological Chemistry.
[122] P. Hass,et al. Structure of C3b in complex with CRIg gives insights into regulation of complement activation , 2006, Nature.
[123] H. E. Gilbert,et al. The 15 SCR Flexible Extracellular Domains of Human Complement Receptor Type 2 can Mediate Multiple Ligand and Antigen Interactions , 2006 .
[124] M. Kurrer,et al. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation. , 2006, The Journal of clinical investigation.
[125] Rengasamy Asokan,et al. Characterization of Human Complement Receptor Type 2 (CR2/CD21) as a Receptor for IFN-α: A Potential Role in Systemic Lupus Erythematosus1 , 2006, The Journal of Immunology.
[126] J. Klco,et al. Genetic Analysis of the First and Third Extracellular Loops of the C5a Receptor Reveals an Essential WXFG Motif in the First Loop* , 2006, Journal of Biological Chemistry.
[127] L. Diehl,et al. CRIg: A Macrophage Complement Receptor Required for Phagocytosis of Circulating Pathogens , 2006, Cell.
[128] H. E. Gilbert,et al. Extended flexible linker structures in the complement chimaeric conjugate CR2-Ig by scattering, analytical ultracentrifugation and constrained modelling: implications for function and therapy. , 2006, Journal of molecular biology.
[129] M. Oppermann,et al. G Protein-coupled Receptor Kinases Promote Phosphorylation and β-Arrestin-mediated Internalization of CCR5 Homo- and Hetero-oligomers* , 2005, Journal of Biological Chemistry.
[130] J. Lescar,et al. The Crystal Structure of the Plexin-Semaphorin-Integrin Domain/Hybrid Domain/I-EGF1 Segment from the Human Integrin β2 Subunit at 1.8-Å Resolution* , 2005, Journal of Biological Chemistry.
[131] J. Parkinson,et al. Large-scale modelling as a route to multiple surface comparisons of the CCP module family. , 2005, Protein engineering, design & selection : PEDS.
[132] A. Higginbottom,et al. Comparative Agonist/Antagonist Responses in Mutant Human C5a Receptors Define the Ligand Binding Site* , 2005, Journal of Biological Chemistry.
[133] D. Soares,et al. Complement Control Protein Modules in the Regulators of Complement Activation , 2005 .
[134] J. Klco,et al. Essential role for the second extracellular loop in C5a receptor activation , 2005, Nature Structural &Molecular Biology.
[135] H. E. Gilbert,et al. Solution structure of the complex between CR2 SCR 1-2 and C3d of human complement: an X-ray scattering and sedimentation modelling study. , 2005, Journal of molecular biology.
[136] Rengasamy Asokan,et al. Mutational analysis of the complement receptor type 2 (CR2/CD21)-C3d interaction reveals a putative charged SCR1 binding site for C3d. , 2005, Journal of molecular biology.
[137] H. Miettinen,et al. Different Endocytosis Pathways of the C5a Receptor and the N‐formyl Peptide Receptor , 2005, Traffic.
[138] M. Barker,et al. The use of membrane translocating peptides to identify sites of interaction between the C5a receptor and downstream effector proteins , 2004, Immunology.
[139] E. Peerschke,et al. cC1q-R (calreticulin) and gC1q-R/p33: ubiquitously expressed multi-ligand binding cellular proteins involved in inflammation and infection. , 2004, Molecular immunology.
[140] K. Bromek,et al. Backbone dynamics of complement control protein (CCP) modules reveals mobility in binding surfaces , 2004, Protein science : a publication of the Protein Society.
[141] P. Taylor,et al. Murine CD93 (C1qRp) Contributes to the Removal of Apoptotic Cells In Vivo but Is Not Required for C1q-Mediated Enhancement of Phagocytosis1 , 2004, The Journal of Immunology.
[142] Somasekar Seshagiri,et al. The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment. , 2003, Genome research.
[143] H. Choe,et al. Sulfation of Tyrosine 174 in the Human C3a Receptor Is Essential for Binding of C3a Anaphylatoxin* , 2003, Journal of Biological Chemistry.
[144] J. Klco,et al. C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.
[145] Kendall J Blumer,et al. C5a Receptor Oligomerization , 2003, Journal of Biological Chemistry.
[146] J. Krause,et al. C5L2, a nonsignaling C5A binding protein. , 2003, Biochemistry.
[147] H. Schiöth,et al. The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints. , 2003, Molecular pharmacology.
[148] M. Tardif,et al. Direct binding of a fragment of the Wiskott-Aldrich syndrome protein to the C-terminal end of the anaphylatoxin C5a receptor. , 2003, The Biochemical journal.
[149] R. Ames,et al. Structure‐function studies of the C3a‐receptor: C‐terminal serine and threonine residues which influence receptor internalization and signaling , 2003, European journal of immunology.
[150] L. Braun,et al. Phosphorylation of Key Serine Residues Is Required for Internalization of the Complement 5a (C5a) Anaphylatoxin Receptor via a β-Arrestin, Dynamin, and Clathrin-dependent Pathway* , 2003, The Journal of Biological Chemistry.
[151] J. Atkinson,et al. Human complement receptor type 1 (CR1) binds to a major malarial adhesin. , 2002, Trends in molecular medicine.
[152] R. Hynes,et al. Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. , 2002, Molecular biology of the cell.
[153] Richard O Hynes,et al. Integrins Bidirectional, Allosteric Signaling Machines , 2002, Cell.
[154] T. Stehle,et al. The crystal structure of human CD21: Implications for Epstein–Barr virus and C3d binding , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[155] P. Gasque,et al. Human C1qRp Is Identical with CD93 and the mNI-11 Antigen But Does Not Bind C1q1 , 2002, The Journal of Immunology.
[156] Stephen C. Blacklow,et al. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation , 2002, Nature Structural Biology.
[157] K. Bromek,et al. Structure of the C3b Binding Site of CR1 (CD35), the Immune Adherence Receptor , 2002, Cell.
[158] P. Monk,et al. The Orphan Receptor C5L2 Has High Affinity Binding Sites for Complement Fragments C5a and C5a des-Arg74 * , 2002, The Journal of Biological Chemistry.
[159] H. E. Gilbert,et al. Solution structures of complement components by X-ray and neutron scattering and analytical ultracentrifugation. , 2001, Biochemical Society transactions.
[160] T. Ugarova,et al. The alternatively spliced αeC domain of human fibrinogen-420 is a novel ligand for leukocyte integrins αMβ2 and αXβ2 , 2001 .
[161] B. Haribabu,et al. Cutting Edge: Differential Regulation of Chemoattractant Receptor-Induced Degranulation and Chemokine Production by Receptor Phosphorylation1 , 2001, The Journal of Immunology.
[162] S. Perkins,et al. Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling. , 2001, Journal of molecular biology.
[163] V. Michael Holers,et al. Structure of Complement Receptor 2 in Complex with Its C3d Ligand , 2001, Science.
[164] J. Kuhn,et al. Sulfated Tyrosines Contribute to the Formation of the C5a Docking Site of the Human C5a Anaphylatoxin Receptor , 2001, The Journal of experimental medicine.
[165] J Hinshelwood,et al. Structural studies in solution of the recombinant N-terminal pair of short consensus/complement repeat domains of complement receptor type 2 (CR2/CD21) and interactions with its ligand C3dg. , 2001, Biochemistry.
[166] J. Atkinson,et al. Structure–function relationships of complement receptor type 1 , 2001, Immunological reviews.
[167] J. Jensenius,et al. Complement Receptor 1/Cd35 Is a Receptor for Mannan-Binding Lectin , 2000, The Journal of experimental medicine.
[168] O. Lichtarge,et al. Genetic Mapping of the Human C5a Receptor , 2000, The Journal of Biological Chemistry.
[169] M. Enomoto,et al. A putative chemoattractant receptor, C5L2, is expressed in granulocyte and immature dendritic cells, but not in mature dendritic cells. , 2000, Molecular immunology.
[170] M. Tardif,et al. Human Complement 5a (C5a) Anaphylatoxin Receptor (CD88) Phosphorylation Sites and Their Specific Role in Receptor Phosphorylation and Attenuation of G Protein-mediated Responses , 2000, The Journal of Biological Chemistry.
[171] W. Prodinger. Complement receptor type two (CR2,CR21) , 1999, Immunologic research.
[172] D. Hourcade,et al. Decay Accelerating Activity of Complement Receptor Type 1 (CD35) , 1999, The Journal of Biological Chemistry.
[173] Martin Oppermann,et al. Ligand‐induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by G protein‐coupled receptor kinases , 1999, European journal of immunology.
[174] O. Lichtarge,et al. C5a Receptor Activation , 1999, The Journal of Biological Chemistry.
[175] R. Ye,et al. Role of the Second Extracellular Loop of Human C3a Receptor in Agonist Binding and Receptor Function* , 1999, The Journal of Biological Chemistry.
[176] O. Götze,et al. C3a(desArg) does not bind to and signal through the human C3a receptor. , 1999, Immunology letters.
[177] H. Sarau,et al. Chimeric Receptors of the Human C3a Receptor and C5a Receptor (CD88)* , 1999, The Journal of Biological Chemistry.
[178] B. Finzel,et al. Cation binding to the integrin CD11b I domain and activation model assessment. , 1998, Structure.
[179] M. Grossmann,et al. G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.
[180] W. Boyar,et al. Residues 21–30 within the Extracellular N-terminal Region of the C5a Receptor Represent a Binding Domain for the C5a Anaphylatoxin* , 1998, The Journal of Biological Chemistry.
[181] D. K. Smith,et al. Sequence profiles of immunoglobulin and immunoglobulin-like domains. , 1997, Journal of molecular biology.
[182] T. Hugli,et al. Complement factors and their receptors. , 1997, Immunopharmacology.
[183] F. Boulay,et al. Internalization and recycling of the C5a anaphylatoxin receptor: evidence that the agonist-mediated internalization is modulated by phosphorylation of the C-terminal domain. , 1997, Journal of cell science.
[184] L. Klickstein,et al. Complement receptor type 1 (CR1, CD35) is a receptor for C1q. , 1997, Immunity.
[185] P. Monk,et al. The C terminus of the human C5a receptor (CD88) is required for normal ligand‐dependent receptor internalization , 1997, European journal of immunology.
[186] Timothy A. Springer,et al. Folding of the N-terminal, ligand-binding region of integrin α-subunits into a β-propeller domain , 1997 .
[187] R. Hertzberg,et al. Molecular Cloning and Characterization of the Human Anaphylatoxin C3a Receptor* , 1996, The Journal of Biological Chemistry.
[188] J. Köhl,et al. Expression cloning of the human C3a anaphylatoxin receptor (C3aR) from differentiated U‐937 cells , 1996, European journal of immunology.
[189] L. Brouchon,et al. Identification of the Major Phosphorylation Sites in Human C5a Anaphylatoxin Receptor in Vivo(*) , 1995, The Journal of Biological Chemistry.
[190] Y. Wong,et al. The human chemoattractant complement C5a receptor inhibits cyclic AMP accumulation through Gi and Gz proteins. , 1995, Biochemical and biophysical research communications.
[191] R. Liddington,et al. Crystal structure of the A domain from the a subunit of integrin CR3 (CD11 b/CD18) , 1995, Cell.
[192] L. Wennogle,et al. Stabilization of C5a receptor–G‐protein interactions through ligand binding , 1994, Journal of cellular biochemistry.
[193] J. Demartino,et al. The amino terminus of the human C5a receptor is required for high affinity C5a binding and for receptor activation by C5a but not C5a analogs. , 1994, The Journal of biological chemistry.
[194] M. Diamond,et al. The leukocyte integrin p150,95 (CD11c/CD18) as a receptor for iC3b. Activation by a heterologous beta subunit and localization of a ligand recognition site to the I domain. , 1994, Journal of immunology.
[195] J. Demartino,et al. Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[196] F. Boulay,et al. The NH2-terminal region of C5aR but not that of FPR is critical for both protein transport and ligand binding. , 1994, The Journal of biological chemistry.
[197] D. Burton,et al. Generation of chimeric C5a/formyl peptide receptors: towards the identification of the human C5a receptor binding site , 1994, European journal of immunology.
[198] B. Eisfelder,et al. Selective coupling of the human anaphylatoxin C5a receptor and α16 in human kidney 293 cells , 1993 .
[199] M. Simon,et al. Specific interactions of chemoattractant factor receptors with G-proteins. , 1993, The Journal of biological chemistry.
[200] V. Vetvicka,et al. CR3 (CD11b, CD18): a phagocyte and NK cell membrane receptor with multiple ligand specificities and functions , 1993, Clinical and experimental immunology.
[201] D. Montefiori,et al. Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21) , 1993, Journal of virology.
[202] M. Tardif,et al. Agonist-dependent phosphorylation of N-formylpeptide and activation peptide from the fifth component of C (C5a) chemoattractant receptors in differentiated HL60 cells. , 1993, Journal of immunology.
[203] M. Diamond,et al. The I domain is a major recognition site on the leukocyte integrin Mac- 1 (CD11b/CD18) for four distinct adhesion ligands , 1993, The Journal of cell biology.
[204] D. Montefiori,et al. CD4‐independent binding of HIV‐1 to the B lymphocyte receptor CR2 (CD21) in the presence of complement and antibody , 1992, Clinical and experimental immunology.
[205] J. Bonnefoy,et al. CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.
[206] G. Carter,et al. Structure-function studies in a series of carboxyl-terminal octapeptide analogues of anaphylatoxin C5a. , 1992, Journal of medicinal chemistry.
[207] G. Carter,et al. Identification and synthesis of a receptor binding site of human anaphylatoxin C5a. , 1991, Journal of medicinal chemistry.
[208] M. Walport. The third component of complement (current topics in microbiology and immunology) , 1991 .
[209] S. Mathur,et al. Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. , 1991, The EMBO journal.
[210] M. Tardif,et al. Expression cloning of a receptor for C5a anaphylatoxin on differentiated HL-60 cells. , 1991, Biochemistry.
[211] C. Gerard,et al. The chemotactic receptor for human C5a anaphylatoxin , 1991, Nature.
[212] I. Campbell,et al. Secondary structure of a complement control protein module by two-dimensional 1H NMR. , 1991, Biochemistry.
[213] M. Springer,et al. Interaction between the C5a receptor and Gi in both the membrane-bound and detergent-solubilized states. , 1990, The Journal of biological chemistry.
[214] Timothy A. Springer,et al. Adhesion receptors of the immune system , 1990, Nature.
[215] B. Myones,et al. Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. , 1990, The Journal of biological chemistry.
[216] G. R. Carson,et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.
[217] G. Nemerow,et al. Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). , 1989, The Journal of biological chemistry.
[218] D. Fearon,et al. Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2 , 1989, The Journal of experimental medicine.
[219] N. Hogg. The leukocyte integrins. , 1989, Immunology today.
[220] H. Kozono,et al. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme. , 1988, Journal of immunology.
[221] N. Hogg,et al. Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. , 1988, The Journal of clinical investigation.
[222] M. Frank,et al. The complement fragment C3d facilitates phagocytosis by monocytes. , 1987, Immunology.
[223] H. Kozono,et al. Covalent association of C3b with C4b within C5 convertase of the classical complement pathway , 1987, The Journal of experimental medicine.
[224] S. Wright,et al. Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide , 1986, The Journal of experimental medicine.
[225] G. Nemerow,et al. Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2) , 1985, Journal of virology.
[226] P. A. Biro,et al. Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. , 1984, Proceedings of the National Academy of Sciences of the United States of America.
[227] V. Nussenzweig,et al. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes , 1982, The Journal of experimental medicine.
[228] H. Colten,et al. Characterization of the human complement (c3b) receptor with a fluid phase C3b dimer. , 1981, Journal of immunology.
[229] T. Hugli,et al. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[230] H. Müller-Eberhard,et al. Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase. , 1970, The Journal of clinical investigation.
[231] R. A. Nelson. The immune-adherence phenomenon; an immunologically specific reaction between microorganisms and erythrocytes leading to enhanced phagocytosis. , 1953, Science.
[232] M. Garstka,et al. The Controversial C 5 a Receptor C 5 aR 2 : Its Role in Health and Disease , 2017 .
[233] Francisco J Fernández,et al. Choose a Suitable Expression Host: A Survey of Available Protein Production Platforms. , 2016, Advances in experimental medicine and biology.
[234] M. Nonaka. Evolution of the complement system. , 2014, Sub-cellular biochemistry.
[235] A. Erdei,et al. Complement receptor type 1 (CR1, CD35) is a potent inhibitor of B-cell functions in rheumatoid arthritis patients. , 2013, International immunology.
[236] P. Monk,et al. International Union of Pharmacology. LXXXVII. Complement Peptide C5a, C4a, and C3a Receptors , 2013 .
[237] M. Stevenson. of Basic , 2012 .
[238] John D Lambris,et al. Structure of complement fragment C 3 b – factor H and implications for host protection by complement regulators , 2009 .
[239] H. E. Gilbert,et al. The 15 SCR flexible extracellular domains of human complement receptor type 2 can mediate multiple ligand and antigen interactions. , 2006, Journal of molecular biology.
[240] P. Marche,et al. Complement receptors and B lymphocytes. , 2004, Critical reviews in immunology.
[241] R. Lefkowitz,et al. Signalling: Seven-transmembrane receptors , 2002, Nature Reviews Molecular Cell Biology.
[242] P. Gasque,et al. Human C 1 qRp Is Identical with CD 93 and the mNI-11 Antigen But Does Not Bind C 1 q 1 , 2002 .
[243] T. Ugarova,et al. The alternatively spliced a E C domain of human fibrinogen-420 is a novel ligand for leukocyte integrins a M b 2 and a X b 2 , 2001 .
[244] M. Carroll,et al. The role of complement and complement receptors in induction and regulation of immunity. , 1998, Annual review of immunology.
[245] J. Köhl,et al. Site-Directed Mutagenesis of Conserved Charged Residues in the Helical Region of the Human C5a Receptor , 1996 .
[246] J. Köhl,et al. Site-directed mutagenesis of conserved charged residues in the helical region of the human C5a receptor. Arg2O6 determines high-affinity binding sites of C5a receptor. , 1996, European journal of biochemistry.
[247] C. Gerard,et al. C5A anaphylatoxin and its seven transmembrane-segment receptor. , 1994, Annual review of immunology.
[248] E. Brown,et al. Complement receptors and phagocytosis. , 1991, Current opinion in immunology.
[249] T. Pozzan,et al. Internalization pathway of C3b receptors in human neutrophils and its transmodulation by chemoattractant receptors stimulation. , 1991, Cell regulation.
[250] H. Rosen,et al. The leukocyte cell surface receptor(s) for the iC3b product of complement. , 1990, Current topics in microbiology and immunology.
[251] M. Frank,et al. Complement receptors. , 1981, Clinical immunology reviews.